COLUMBUS MCKINNON CORP Q2 FY2027 earnings call

• Strong Financial Start: Orders exceeded $560 million for the second consecutive quarter, growing 13% on a pro forma basis. Pro forma sales grew 7% (consolidated) or 6.6% (normalized), driven by broad-based demand across all geographies.
• Keto Crosby Integration: The company is advancing integration with early traction on synergies. Initial focus is on net cost synergies, but revenue synergies via cross-selling are showing promise. Customer feedback post-acquisition has been positive.
• Demand Drivers: Growth is fueled by resilient demand in energy, defense, mobility, e-commerce, and general industrial sectors. Data center buildouts are providing tailwinds for both direct hardware sales and upstream equipment production.
• Geographic Performance: Americas and Asia Pacific volumes are building. EMEA showed modestly positive pro forma growth, improving from expectations due to infrastructure, energy, and defense investments, despite softer PMI data.
• Pricing Power: The company maintains pricing discipline to offset inflationary pressures in raw materials and diesel costs. Pro forma growth attributed ~4 percentage points to price and ~3 percentage points to volume.
• Operational Excellence: Improved customer experience, on-time delivery, and commercial execution have contributed to expanding market share. Supply chain remains resilient despite persistent inflation.
• Social Impact: Highlighted employee volunteerism in Rwanda, supporting the construction of a suspension bridge to improve rural access to healthcare and schools.

The transcript does not provide a breakdown of financial performance by specific product segment (e.g., lifting, motion control). However, it provides consolidated pro forma results for the quarter: Net sales were $539.3 million (pro forma growth ~6.6%, comprised of ~4% price and ~3% volume). Adjusted EBITDA was $111.2 million, representing a margin of 20.6%. Gross profit was $187.9 million with an adjusted gross margin of 36.5%.

• Raised Full-Year FY2027 Guidance: Management raised outlooks for net sales, adjusted EBITDA, and adjusted EPS based on strong H1 performance and increased confidence in synergy realization.
• Net Sales: Revised to $2.13 billion to $2.17 billion.
• Adjusted EBITDA: Revised to $425 million to $440 million.
• Adjusted EPS: Revised to $2.00 to $2.15 per share.
• Key Assumptions: Interest expense of $185–$190 million; Amortization of $130–$135 million; Depreciation of $80–$85 million; CapEx of $45–$55 million; Effective tax rate of 25%; Diluted shares outstanding of 52 million.
• Margin Expectations: Management expects sustained strong adjusted EBITDA margins in H2, normalizing out one-time IEPA tariff refunds from Q1. Implied H2 margin is similar to the normalized H1 margin (~19.7%).
• Leverage Target: Confident in achieving a leverage ratio of 4x by the end of FY28, driven by core EBITDA growth and free cash flow generation.

• Macroeconomic Volatility: Industrial activity in EMEA remains softer compared to other regions, consistent with global PMI data.
• Inflationary Pressures: Persistent inflation in material costs and diesel fuel requires continuous pricing adjustments to protect margins.
• Geopolitical/Logistical Challenges: Shipping routes to the Middle East remain challenging and less efficient, potentially increasing delivery times.
• Integration Execution: While early progress is strong, realizing full revenue and cost synergies from the Keto Crosby acquisition requires time to align sales forces, channels, and supply chains.
• Working Capital Fluctuations: Significant working capital investment in H1 tied to sales growth may impact cash flow until converted in H2.

Q: Analyst asked if the Q2 margin cadence remains intact given previous expectations of a low point, and how much growth was sustainable pricing vs. one-time benefits like tariffs. / A: CEO explained that Q1 included one-time IEPA tariff refunds, leading to prior expectations of a Q2 low. However, robust short-cycle demand and accelerated project deliveries in Asia/Europe led to over-performance. CFO noted no material one-time skewers in Q2 margins. Excluding Q1 tariffs, normalized H1 margin was ~19.7%, and management expects H2 margins to sustain this level, signaling durable pricing power rather than transient benefits.

Q: Analyst inquired about the potential size and sources of revenue synergies and market share gains from the Keto Crosby combination. / A: CEO stated that revenue synergies are visible globally as the combined portfolio allows cross-selling legacy CMCO products into Keto Crosby channels and vice versa. Customer feedback has been favorable due to expanded offerings and improved service. While initial gains may be weighted toward the Americas due to concentration, the broader reach and enhanced value proposition are driving market share opportunities across all regions.

Q: Analyst requested details on free cash flow cadence for the rest of the year and whether any Q2 project revenue was pulled forward. / A: CFO explained that H1 working capital was a use of cash due to an ~$80M pro forma sales increase, locking up funds in AR and inventory. He expects this to unlock in H2, making FCF significantly weighted to the back half. Regarding Q2, only one ~$5M high-margin project in APAC was pulled forward; otherwise, sales were normal. Strong September short-cycle sales in the U.S. also contributed to the strong finish.

Q: Analyst asked about the drivers of stronger-than-expected demand in EMEA and if Middle East shipping bottlenecks are cleared. / A: CEO identified energy, general industrial, and defense as primary demand drivers in Europe, alongside a major Saudi Arabia energy project. Regarding logistics, he confirmed that while Middle East routes are still challenging and less efficient than pre-acquisition levels, they have found ways to navigate and deliver products, though delivery times are longer.

Q: Analyst sought clarity on the leverage journey, specifically the path to the 4x target by FY28 and the role of working capital improvements. / A: CFO reiterated confidence in hitting 4x leverage by FY28, requiring both core EBITDA growth and significant FCF generation. He highlighted that improving inventory turns (currently ~2.5x, targeting 3x) and DSO/DPO would unlock substantial cash. CEO added that revenue synergy upside exists beyond current guidance, but they do not expect materially different macro conditions in FY28/29 to support these targets, relying instead on sustained activity and execution.